Evidence map›Paper›PMID 35069073›Full record

ReviewPrzeglad menopauzalny = Menopause review2021

A novel tool for visualization and detection of pancreatic neuroendocrine tumours. A 'fluorescent' world is calling for exploration?

Maria Sotiropoulou, Francesk Mulita, Georgios-Ioannis Verras, Dimitrios Schizas, Alexandros Papalampros, Levan Tchabashvili, Charalampos Kaplanis, Elias Liolis, Ioannis Perdikaris, Ioannis Maroulis and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Przeglad menopauzalny = Menopause review, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Maria SotiropoulouDepartment of Surgery, National and Kapodistrian University of Athens, Athens, Greece.
Francesk MulitaDepartment of Surgery, General University Hospital of Patras, Greece.
Georgios-Ioannis VerrasDepartment of Surgery, General University Hospital of Patras, Greece.
Dimitrios SchizasDepartment of Surgery, National and Kapodistrian University of Athens, Athens, Greece.
Alexandros PapalamprosDepartment of Surgery, National and Kapodistrian University of Athens, Athens, Greece.
Levan TchabashviliDepartment of Surgery, General University Hospital of Patras, Greece.
Charalampos KaplanisDepartment of Surgery, General University Hospital of Patras, Greece.
Elias LiolisDepartment of Internal Medicine, Division of Oncology, General University Hospital of Patras, Greece.
Ioannis PerdikarisDepartment of Surgery, General University Hospital of Patras, Greece.
Ioannis MaroulisDepartment of Surgery, General University Hospital of Patras, Greece.
Michail VailasDepartment of Surgery, General University Hospital of Patras, Greece.
General University Hospital of Patras · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aim of the studyPancreatic neuroendocrine tumours (pNETs) are rare tumours with a propensity to metastasize. Physicians frequently face a huge clinical challenge during the localization of these lesions. The aim of this study is to investigate whether fluorescence-guided localization techniques with indocyanine green (ICG) can be utilized as a detection tool in pNETs, along with any other clinical implications of this technique. MATERIAL AND

methodsA thorough literature search in PubMed and Google Scholar, under the terms 'ICG OR Indocyanine OR Fluorescence AND Neuroendocrine' until 31 June 2021, regarding the utilization of indocyanine-fluorescence in localization of pancreatic neuroendocrine, was conducted by the authors, and the associated results are presented.

resultsIndocyanine fluorescence imaging may facilitate the efforts of surgeons to identify occult pancreatic neuroendocrine lesions, assisting them in the identification of resection margins and delineation of the surgical anatomy when it is difficult to clarify.

conclusionsIndocyanine-fluorescence imaging might play a pivotal role in pancreatic surgery in terms of localization for neuroendocrine tumours. However, further large-scale clinical studies are needed to assess the absolute indications and optimal use of this technique.

Indexed as

cancerfluorescenceICGindocyanineneuroendocrinepancreas

Identifiers

PMID35069073
PMCPMC8764961
OpenAlexW3211777482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.